Patient-Centered Cancer Prevention In Chinese Americans

Status Completed

Clinical Trial Summary

This study will assess the efficacy, adoption, and impact of an integrated intervention to improve adherence to recommended stomach cancer prevention guidelines (H. pylori test-and-treat) for at-risk Chinese Americans in NYC. The integrated multifaceted theory-based intervention involves: 1) a health systems-level intervention using electronic health record (EHR)-based tools to facilitate H. pylori test-and-treat strategies; and 2) a community-engaged culturally and linguistically adapted CHW-led patient navigation program we are currently pilot testing for feasibility and acceptability. Using a 2-arm randomized controlled trial (RCT) design, > 144 Chinese American patients across NYC safety net hospital endoscopy clinics and primary health centers will participate.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03340454
Study type	Interventional
Source	NYU Langone Health
Contact
Status	Completed
Phase	N/A
Start date	August 15, 2018
Completion date	June 15, 2023

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT06045494` - The Efficacy of Treatment for Helicobacter Pylori Infection in Preschooler by Yoghurt With LG21	N/A
Not yet recruiting	`NCT01449500` - Supplementation With L. Reuteri in H. Pylori Infected Adults	N/A
Completed	`NCT01234389` - Immediate Detection of Helicobacter Infection With a New Electrochemical System.	N/A
Not yet recruiting	`NCT05387005` - Screening Strategy for Gastric Cancer Prevention	N/A
Not yet recruiting	`NCT02761005` - Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. Pylori	Phase 2
Recruiting	`NCT03142620` - Effect of Vitamin D on Drug Resistant Helicobacter Pylori (HP) Eradication Study	Phase 3
Withdrawn	`NCT02090738` - A Randomized, Open-label Study on Helicobacter Pylori Eradication With Standard Triple Regimen Plus Acetazolamide	Phase 2
Recruiting	`NCT01335334` - H. Pylori Eradication Using Pyklear in Adults in El Paso, Texas: a Pilot Study	Phase 4
Recruiting	`NCT05544396` - Study on the Probiotics Regulating miRNA in H. Pylori-induced Wnt/β-catenin Gastric Carcinogenesis.	N/A
Recruiting	`NCT04713670` - Comparison of Vonoprazan-based Versus Lansoprazole-based Triple Therapy, High Dose Dual Therapy, Bismuth and Non-bismuth Quadruple Therapy in the First-line Treatment of Helicobacter Pylori Infection	Phase 4
Recruiting	`NCT06045832` - Oral Helicobacter Pylori Eradication	N/A
Completed	`NCT05453994` - Bismuth for PCAB-based H. Pylori Eradication
Recruiting	`NCT02328131` - European Registry on the Management of Helicobacter Pylori Infection
Completed	`NCT00197457` - Pepsinogens as the Early Marker of H. Pylori Eradication	Phase 2
Not yet recruiting	`NCT06412640` - Optimization of Keverprazan-amoxicilli Dual Therapy for Helicobacter Pylori	Phase 4
Completed	`NCT04036838` - ARJ C13 Urea Breath Test System	Phase 2
Completed	`NCT06050824` - A Comparative Study Between Concomitant Versus Load Therapy in Eradication of Helicobacter Pylori Infection	Phase 4
Completed	`NCT02767479` - Comparison of Rabeprazole and Esomperazole for the Eradication of H. Pylori	Phase 3
Completed	`NCT01505127` - Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori	Phase 3
Recruiting	`NCT05176821` - Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection	N/A